Gan & Lee Pharmaceuticals. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 558 million compared to CNY 689.99 million a year ago.

Net income was CNY 49.22 million compared to CNY 113.3 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.09 compared to CNY 0.2 a year ago.